Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (
C57BL/6 mice
H3 receptor
M39
antagonist
ulcer
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
03
2019
accepted:
29
07
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
2
10
2019
Statut:
epublish
Résumé
The role of histamine H3 receptors (H3Rs) in the regulation of gastroprotection and production of prostaglandin E2 (PGE2) as well as somatostatin remains contradictory. Therefore, the effects of the H3R antagonist/inverse agonist M39 on
Identifiants
pubmed: 31572174
doi: 10.3389/fphar.2019.00966
pmc: PMC6751319
doi:
Types de publication
Journal Article
Langues
eng
Pagination
966Informations de copyright
Copyright © 2019 Bastaki, Amir, Więcek, Kieć-Kononowicz and Sadek.
Références
Gastroenterology. 1997 Nov;113(5):1545-52
pubmed: 9352856
Pharmacol Res. 2018 Mar;129:515-525
pubmed: 29217157
Eur J Pharmacol. 2011 Nov 1;669(1-3):121-7
pubmed: 21839070
Inflamm Res. 1995 Apr;44 Suppl 1:S106-7
pubmed: 8520975
Expert Opin Ther Pat. 2018 Mar;28(3):175-196
pubmed: 29334795
Front Biosci (Schol Ed). 2012 Jan 01;4:226-39
pubmed: 22202056
Drug Des Devel Ther. 2016 Nov 25;10:3879-3898
pubmed: 27932863
Neuroscience. 1985 Jun;15(2):553-62
pubmed: 4022339
Annu Rev Physiol. 1979;41:35-53
pubmed: 219762
Digestion. 1995;56(2):145-52
pubmed: 7750668
Gastroenterology. 1998 Jul;115(1):245-7
pubmed: 9659346
Dig Dis Sci. 1997 May;42(5):1020-8
pubmed: 9149057
Inflamm Res. 2005 Apr;54 Suppl 1:S48-9
pubmed: 15928831
Neurobiol Dis. 2008 Apr;30(1):74-83
pubmed: 18295497
Neuroscience. 1987 Oct;23(1):149-57
pubmed: 2446202
Drug Des Devel Ther. 2016 Nov 07;10:3633-3651
pubmed: 27853355
Asian Pac J Trop Med. 2011 Sep;4(9):673-9
pubmed: 21967687
Clin Exp Pharmacol Physiol. 2002 Mar;29(3):173-80
pubmed: 11906479
J Neural Transm Suppl. 2003;(64):1-16
pubmed: 12830926
Mol Neurobiol. 2017 Aug;54(6):4537-4550
pubmed: 27370794
Mol Cell Biochem. 2003 Oct;252(1-2):83-90
pubmed: 14577579
Trends Pharmacol Sci. 2007 Jul;28(7):350-7
pubmed: 17573125
J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21
pubmed: 15947036
Eur J Pharmacol. 1993 Mar 30;234(1):129-33
pubmed: 8386092
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4886-91
pubmed: 23891186
Mol Pharmacol. 1999 Jun;55(6):1101-7
pubmed: 10347254
J Physiol Pharmacol. 2001 Dec;52(4 Pt 1):539-53
pubmed: 11787757
Eur J Cell Biol. 2008 Apr;87(4):227-36
pubmed: 18258331
Br J Pharmacol. 2009 May;157(1):64-75
pubmed: 19413572
J Physiol. 2007 Sep 1;583(Pt 2):731-42
pubmed: 17627982
J Biol Chem. 2011 Feb 18;286(7):5846-54
pubmed: 21173143
Naunyn Schmiedebergs Arch Pharmacol. 1993 Jan;347(1):61-5
pubmed: 8383301
Biochem Pharmacol. 2007 Apr 15;73(8):1195-204
pubmed: 17276412
Behav Pharmacol. 2014 Jun;25(3):245-52
pubmed: 24776492
Inflamm Res. 2008;57 Suppl 1:S57-8
pubmed: 18345490
Br J Pharmacol. 2000 Apr;129(8):1597-600
pubmed: 10780963
Br J Pharmacol. 2009 May;157(1):24-33
pubmed: 19309354
Mol Pharmacol. 2006 Apr;69(4):1194-206
pubmed: 16415177
Neuropharmacology. 2016 Jul;106:56-73
pubmed: 26581501
Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):218-23
pubmed: 7990981
Bioorg Med Chem. 2008 Dec 1;16(23):9911-24
pubmed: 18976927
Neuropharmacology. 2016 Jul;106:46-55
pubmed: 26525191
J Pharmacol Exp Ther. 1992 Oct;263(1):304-10
pubmed: 1383495
Eur J Pharmacol. 2005 Oct 17;522(1-3):130-8
pubmed: 16213481
J Med Chem. 1994 Feb 4;37(3):332-3
pubmed: 8308858
Gut. 2006 Apr;55(4):498-504
pubmed: 16299042
Br J Pharmacol. 2009 May;157(1):14-23
pubmed: 19413568
J Pharmacol Exp Ther. 2011 Jan;336(1):17-23
pubmed: 20864502
Eur J Pharmacol. 1993 Feb 23;232(1):99-103
pubmed: 8384565
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6807-15
pubmed: 16203768
J Pharmacol Exp Ther. 2004 Apr;309(1):404-13
pubmed: 14722321
Nat Rev Drug Discov. 2008 Jan;7(1):41-53
pubmed: 18172439
Pharmacol Rev. 2015 Jul;67(3):601-55
pubmed: 26084539
Life Sci. 2003 Oct 31;73(24):3043-72
pubmed: 14550847
Histol Histopathol. 2008 Jul;23(7):789-98
pubmed: 18437677
Eur J Pharmacol. 2007 Jun 1;563(1-3):240-4
pubmed: 17382315
Inflamm Res. 2003 Apr;52 Suppl 1:S33-4
pubmed: 12755399
Dig Dis Sci. 1995 Mar;40(3):651-60
pubmed: 7895561
Bioorg Med Chem. 2011 May 1;19(9):2850-8
pubmed: 21498080
Eur J Pharmacol. 2000 Mar 24;392(1-2):23-9
pubmed: 10748268
Neuropharmacology. 2008 Aug;55(2):190-7
pubmed: 18547596
Eur J Pharmacol. 1994 Jul 1;259(2):107-14
pubmed: 7957603
Nature. 1983 Apr 28;302(5911):832-7
pubmed: 6188956
Nature. 1987 May 14-20;327(6118):117-23
pubmed: 3033516
J Pharmacol Exp Ther. 1994 Sep;270(3):1256-61
pubmed: 7932178
Behav Brain Res. 2016 Oct 1;312:415-30
pubmed: 27363923
Eur J Med Chem. 2014 Apr 22;77:269-79
pubmed: 24650714
J Clin Med. 2019 Feb 03;8(2):null
pubmed: 30717467
Prog Neurobiol. 2001 Apr;63(6):637-72
pubmed: 11164999
Am J Physiol. 1991 Apr;260(4 Pt 1):G631-5
pubmed: 1850206
J Neurochem. 1988 Jul;51(1):105-8
pubmed: 2454293
J Diet Suppl. 2018 Jul 4;15(4):373-385
pubmed: 28816560